{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:18:00Z","timestamp":1767993480571,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf00919386","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:50:31Z","timestamp":1104540631000},"page":"272-278","source":"Crossref","is-referenced-by-count":72,"title":["Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies"],"prefix":"10.1007","volume":"13","author":[{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Mankarious","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Courter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"312","volume":"2","author":"GN Vyas","year":"1971","unstructured":"Vyas GN, Perkins HA, Fudenberg HH: Anaphylactoid transfusion reaction associated with anti-IgA. Lancet 2:312?314, 1971","journal-title":"Lancet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1056\/NEJM196901232800404","volume":"280","author":"AP Schmidt","year":"1969","unstructured":"Schmidt AP, Taswell HF, Gleich GJ: Anaphylactic transfusion reactions associated with anti-IgA antibody. N Engl J Med 280:188?193, 1969","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-1229(77)90068-X","volume":"7","author":"I Rivat","year":"1977","unstructured":"Rivat I, Rivat C, Daveau M, Ropartz C: Comparative frequencies of anti-IgA antibodies among patients with anaphylactic transfusion reactions and among normal blood donors. Clin Immunol Immunopathol 7:340?348, 1977","journal-title":"Clin Immunol Immunopathol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0090-1229(77)90116-7","volume":"8","author":"JV Wells","year":"1971","unstructured":"Wells JV, Buckley RH, Schanfield MS: Anaphylactoid reactions to plasma infusions in patients with hypogammaglobulinemia and anti-IgA antibodies. Clin Immunol Immunopathol 8:265?271, 1971","journal-title":"Clin Immunol Immunopathol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-3083.1983.tb00885.x","volume":"18","author":"L Hammarstr\u00f6m","year":"1983","unstructured":"Hammarstr\u00f6m L, Persson MAA, Smith CIE: Anti-IgA in selective IgA deficiencyin vitro effects and Ig subclass patterns of human anti-IgA. Scand J Immunol 18:509?513, 1983","journal-title":"Scand J Immunol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-1229(88)90072-4","volume":"47","author":"A Ferreira","year":"1988","unstructured":"Ferreira A, Garcia-Rodriguez MC, Lopez-Trascasa M, Pascual-Salcedo D, Fontan G: Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin. Clin Immunol Immunopathol 47:199?207, 1988","journal-title":"Clin Immunol Immunopathol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM198106113042408","volume":"302","author":"VA Oxelius","year":"1981","unstructured":"Oxelius VA, Laurell AB, Lindqvist B, Golebiowska M, Axelsson U, Bj\u00f6rkander J, Hanson L\u00c5: IgG subclasses in selective IgA deficiency. Importance of IgG2-IgA deficiency. N Engl J Med 302:1476?1477, 1981","journal-title":"N Engl J Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9343(84)90314-0","volume":"76","author":"VA Oxelius","year":"1984","unstructured":"Oxelius VA: Immunoglobulin (IgG) subclasses and human disease. Am J Med 76:7?18, 1984","journal-title":"Am J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00915419","volume":"7","author":"J Bj\u00f6rkander","year":"1987","unstructured":"Bj\u00f6rkander J, Hammarstr\u00f6m L, Smith CI, Buckley RH, Cunningham-Rundles C, Hanson L\u00c5: Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. J Clin Immunol 7:8?15, 1987","journal-title":"J Clin Immunol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0090-1229(86)90133-9","volume":"38","author":"C Cunningham-Rundles","year":"1986","unstructured":"Cunningham-Rundles C, Wong S, Bj\u00f6rkander J, Hanson L\u00c5: Use of an IgA-depleted intravenous immunoglobulin in a patient with an IgA antibody. Clin Immunol Immunopathol 38:141?9, 1986","journal-title":"Clin Immunol Immunopathol"},{"key":"CR11","first-page":"157","volume":"20","author":"J Bj\u00f6rkander","year":"1986","unstructured":"Bj\u00f6rkander J, Bengtsson U, Oxelius VA, Hanson L\u00c5: Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency and effects of immunoglobulin prophylaxis. Monogr Allergy 20:157?163, 1986","journal-title":"Monogr Allergy"},{"key":"CR12","first-page":"443","volume-title":"Laboratory and Research Methods in Biology and Medicine","author":"TE Hugli","year":"1980","unstructured":"Hugli TE, Chenoweth DF: Biologically active peptides of complement: Techniques and significance of C3a and C5a measurements.In Laboratory and Research Methods in Biology and Medicine, RM Nakamusa, WR Dito (eds.), New York, Alan R. Liss, 1980, p 443"},{"key":"CR13","first-page":"25","volume":"3A","author":"NK Day","year":"1984","unstructured":"Day NK, Good RA, Wahn V: Adverse reaction in selected patients following intravenous infusions of gammaglobulin. Am J Med Suppl 3A:25?31, 1984","journal-title":"Am J Med Suppl"},{"key":"CR14","first-page":"223","volume-title":"Immunohemotherapy","author":"S Barandun","year":"1981","unstructured":"Barandun S, Morrell A: Adverse reactions to immunoglobulin preparations.In Immunohemotherapy, UE Nydegger (ed). London, Academic Press, 1981, pp 223?230"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-101-4-435","volume":"101","author":"C Cunningham-Rundles","year":"1984","unstructured":"Cunningham-Rundles C, Siegal FP, Smithwick EM, Cunningham-Rundles S, Lion-Boule A, O'Malley J, Barandun S, Good RA: Efficacy of intravenous gammaglobulin in humoral immunodeficiency disease. Ann Intern Med 101:435?439, 1984","journal-title":"Ann Intern Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0090-1229(82)90022-8","volume":"22","author":"AJ Ammann","year":"1982","unstructured":"Ammann AJ, Ashman RF, Buckley RH, Hardie WR, Krantman HJ, Nelson J, Ochs H, Stiehm ER, Tiller T, Wara DW, Wedgewood R: Use of intravenous gammaglobulin in antibody immunodeficiency: Results of a multicenter controlled trial. Clin Immunol Immunopathol 22:60?67, 1982","journal-title":"Clin Immunol Immunopathol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/0003-4819-107-2-367","volume":"107","author":"ER Stiehm","year":"1987","unstructured":"Stiehm ER, Ashida E, Kim KS, Winston DJ, Haas A, Gale RP: Intravenous immunoglobulin as therapeutic agents. Ann Intern Med 107:367?382, 1987","journal-title":"Ann Intern Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00915377","volume":"6","author":"C Cunningham-Rundles","year":"1986","unstructured":"Cunningham-Rundles C, Carr RI: Dietary bovine antigens and immune complex formation after intravenous immunoglobulin in common variable immunodeficiency. J Clin Immunol 6:381?388, 1986","journal-title":"J Clin Immunol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.1990.tb05171.x","volume":"79","author":"G Zilow","year":"1990","unstructured":"Zilow G, Sturm JA, Rother U, Kirschfink M: Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin Exp Immunol 79:151?157, 1990","journal-title":"Clin Exp Immunol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0090-1229(85)90067-4","volume":"35","author":"JS Sundsmo","year":"1985","unstructured":"Sundsmo JS, Papin RA, Wood L, Hirani S, Waldeck N, Buckingham B, Kershnar A, Ascher M, Charles MA: Complement activation in Type 1 human diabetes. Clin Immunol Immunopathol 35:211?225, 1985","journal-title":"Clin Immunol Immunopathol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM198410043111403","volume":"311","author":"RM Hakim","year":"1984","unstructured":"Hakim RM, Breillatt J, Lazarus MJ, Port F: Complement activation and hyper-sensitivity reactions to dialysis membranes. N Engl J Med 311:878?882, 1984","journal-title":"N Engl J Med"},{"key":"CR22","first-page":"447","volume-title":"In Reaction to Intravenous Gammaglobulin Infusions and Immune Complex Formation, Immunohemotherapy","author":"C Cunningham-Rundles","year":"1981","unstructured":"Cunningham-Rundles C, Day NK, Wahn V, Smithwick EM, Siegal FP, Gupta S, Good RA: In Reaction to Intravenous Gammaglobulin Infusions and Immune Complex Formation, Immunohemotherapy, UE Nydegger (ed). London, Academic Press, London, 1981, pp 447?449"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198602273140907","volume":"314","author":"AW Burks","year":"1986","unstructured":"Burks AW, Sampson HA, Buckley RH: Anaphylactic reactions after gammaglobulin administration in patients with hypogammaglobulinemia. N Engl J Med 314:560?562, 1986","journal-title":"N Engl J Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000460851","volume":"42","author":"J Romer","year":"1982","unstructured":"Romer J, Morgenthaler JJ, Scherz R, Skvaril F: Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content. Vox Sang 42:62?73, 1982","journal-title":"Vox Sang"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00919386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00919386\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00919386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T11:39:31Z","timestamp":1556537971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00919386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF00919386"],"URL":"https:\/\/doi.org\/10.1007\/bf00919386","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}